Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 450

1.

Glutathione S-transferase Pi 1 is a valuable predictor for cancer drug resistance in esophageal squamous cell carcinoma.

Ogino S, Konishi H, Ichikawa D, Matsubara D, Shoda K, Arita T, Kosuga T, Komatsu S, Shiozaki A, Okamoto K, Kishimoto M, Otsuji E.

Cancer Sci. 2018 Nov 30. doi: 10.1111/cas.13896. [Epub ahead of print]

2.

Urinary Level of Liver-Type Fatty Acid Binding Protein Reflects the Degree of Tubulointerstitial Damage in Polycystic Kidney Disease.

Watanabe S, Ichikawa D, Sugaya T, Ohata K, Inoue K, Hoshino S, Kimura K, Shibagaki Y, Kamijo-Ikemori A.

Kidney Blood Press Res. 2018 Nov 23;43(6):1716-1729. doi: 10.1159/000495389. [Epub ahead of print]

3.

Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer.

Kawaida H, Kono H, Amemiya H, Saitou R, Yamamoto A, Hosomura N, Watanabe M, Kimura A, Furuya S, Shimizu H, Akaike H, Kawaguchi Y, Sudo M, Itakura J, Hayakawa H, Shindo H, Takahashi EI, Takano S, Fukasawa M, Ichikawa S, Fujii H, Ichikawa D.

Anticancer Res. 2018 Nov;38(11):6537-6542. doi: 10.21873/anticanres.13019.

PMID:
30396983
4.

miR-122-5p as a novel biomarker for alpha-fetoprotein-producing gastric cancer.

Maruyama S, Furuya S, Shiraishi K, Shimizu H, Akaike H, Hosomura N, Kawaguchi Y, Amemiya H, Kawaida H, Sudo M, Inoue S, Kono H, Ichikawa D.

World J Gastrointest Oncol. 2018 Oct 15;10(10):344-350. doi: 10.4251/wjgo.v10.i10.344.

5.

A novel derivative (GTN024) from a natural product, komaroviquinone, induced the apoptosis of high-risk myeloma cells via reactive oxygen production and ER stress.

Okayama M, Kitabatake S, Sato M, Fujimori K, Ichikawa D, Matsushita M, Suto Y, Iwasaki G, Yamada T, Kiuchi F, Hirao M, Kunieda H, Osada M, Okamoto S, Hattori Y.

Biochem Biophys Res Commun. 2018 Nov 2;505(3):787-793. doi: 10.1016/j.bbrc.2018.09.177. Epub 2018 Oct 5.

PMID:
30297108
6.

[A Case of Triple Negative Breast Cancer Successfully Treated with S-1].

Nakayama Y, Inoue S, Mimura K, Nakazawa T, Kimura A, Ohmori M, Matsuda K, Ichikawa D.

Gan To Kagaku Ryoho. 2018 Sep;45(9):1343-1346. Japanese.

PMID:
30237378
7.

Functional analysis and clinical significance of sodium iodide symporter expression in gastric cancer.

Shiozaki A, Ariyoshi Y, Iitaka D, Kosuga T, Shimizu H, Kudou M, Konishi T, Shoda K, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Marunaka Y, Ichikawa D, Otsuji E.

Gastric Cancer. 2018 Sep 6. doi: 10.1007/s10120-018-0874-2. [Epub ahead of print]

PMID:
30191346
8.

Hepatic ductoplasty for iatrogenic Bismuth type 2 bile duct stricture: A case report.

Hirotaka O, Takahashi K, Hiroyuki W, Kawashima K, Ichikawa D, Hideki F.

Int J Surg Case Rep. 2018;51:161-164. doi: 10.1016/j.ijscr.2018.08.025. Epub 2018 Aug 19.

9.

Tubulointerstitial Nephritis Associated with Enteritis and Sacroiliitis.

Ushimaru S, Ichikawa D, Yazawa M, Suzuki T, Okada E, Koike J, Shibagaki Y.

Intern Med. 2018 Aug 24. doi: 10.2169/internalmedicine.1255-18. [Epub ahead of print]

10.

Lipid moiety of glycosylphosphatidylinositol-anchored proteins contributes to the determination of their final destination in yeast.

Yoko-O T, Umemura M, Komatsuzaki A, Ikeda K, Ichikawa D, Takase K, Kanzawa N, Saito K, Kinoshita T, Taguchi R, Jigami Y.

Genes Cells. 2018 Oct;23(10):880-892. doi: 10.1111/gtc.12636. Epub 2018 Oct 1.

PMID:
30133879
11.

Using machine-learning approaches to predict non-participation in a nationwide general health check-up scheme.

Shimoda A, Ichikawa D, Oyama H.

Comput Methods Programs Biomed. 2018 Sep;163:39-46. doi: 10.1016/j.cmpb.2018.05.032. Epub 2018 May 29.

PMID:
30119856
12.

Integration Mapping of piggyBac-Mediated CD19 Chimeric Antigen Receptor T Cells Analyzed by Novel Tagmentation-Assisted PCR.

Hamada M, Nishio N, Okuno Y, Suzuki S, Kawashima N, Muramatsu H, Tsubota S, Wilson MH, Morita D, Kataoka S, Ichikawa D, Murakami N, Taniguchi R, Suzuki K, Kojima D, Sekiya Y, Nishikawa E, Narita A, Hama A, Kojima S, Nakazawa Y, Takahashi Y.

EBioMedicine. 2018 Aug;34:18-26. doi: 10.1016/j.ebiom.2018.07.008. Epub 2018 Aug 3.

13.

Clinical Impact of Histological Heterogeneity in the Metastatic Lymph Nodes of Patients with Colorectal Cancer.

Hirayama K, Sudoh M, Shimizu H, Furuya S, Akazawa Y, Iino H, Shiraishi K, Akaike H, Hosomura N, Kawaguchi Y, Amemiya H, Kawaida H, Inoue S, Kono H, Fujii H, Ichikawa D.

Anticancer Res. 2018 Aug;38(8):4797-4803. doi: 10.21873/anticanres.12789.

PMID:
30061251
14.

Aquaporin 1 suppresses apoptosis and affects prognosis in esophageal squamous cell carcinoma.

Yamazato Y, Shiozaki A, Ichikawa D, Kosuga T, Shoda K, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Marunaka Y, Otsuji E.

Oncotarget. 2018 Jul 6;9(52):29957-29974. doi: 10.18632/oncotarget.25722. eCollection 2018 Jul 6.

15.

Anion exchanger 2 suppresses cellular movement and has prognostic significance in esophageal squamous cell carcinoma.

Shiozaki A, Hikami S, Ichikawa D, Kosuga T, Shimizu H, Kudou M, Yamazato Y, Kobayashi T, Shoda K, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Marunaka Y, Otsuji E.

Oncotarget. 2018 May 25;9(40):25993-26006. doi: 10.18632/oncotarget.25417. eCollection 2018 May 25.

16.

Identification of active and taxonomically diverse 1,4-dioxane degraders in a full-scale activated sludge system by high-sensitivity stable isotope probing.

Aoyagi T, Morishita F, Sugiyama Y, Ichikawa D, Mayumi D, Kikuchi Y, Ogata A, Muraoka K, Habe H, Hori T.

ISME J. 2018 Oct;12(10):2376-2388. doi: 10.1038/s41396-018-0201-2. Epub 2018 Jun 13.

17.

Early Generated B-1-Derived B Cells Have the Capacity To Progress To Become Mantle Cell Lymphoma-like Neoplasia in Aged Mice.

Hayakawa K, Formica AM, Nakao Y, Ichikawa D, Shinton SA, Brill-Dashoff J, Smith MR, Morse HC 3rd, Hardy RR.

J Immunol. 2018 Jul 15;201(2):804-813. doi: 10.4049/jimmunol.1800400. Epub 2018 Jun 13.

18.

Chloride intracellular channel 1 as a switch among tumor behaviors in human esophageal squamous cell carcinoma.

Kobayashi T, Shiozaki A, Nako Y, Ichikawa D, Kosuga T, Shoda K, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Marunaka Y, Otsuji E.

Oncotarget. 2018 May 1;9(33):23237-23252. doi: 10.18632/oncotarget.25296. eCollection 2018 May 1.

19.

Long-term Postoperative Nutritional Status Affects Prognosis Even After Infectious Complications in Gastric Cancer.

Kiuchi J, Komatsu S, Kosuga T, Kubota T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Ichikawa D, Otsuji E.

Anticancer Res. 2018 May;38(5):3133-3138.

PMID:
29715153
20.

Podoplanin Expression as a Prognostic Factor in Gastric Cancer.

Maruyama S, Furuya S, Shiraishi K, Shimizu H, Akaike H, Hosomura N, Kawaguchi Y, Amemiya H, Kawaida H, Sudo M, Inoue S, Kono H, Ichikawa D.

Anticancer Res. 2018 May;38(5):2717-2722.

PMID:
29715091
21.

Can nutcracker phenomenon cause glomerular hematuria?

Suzuki T, Imai N, Hisamichi M, Ichikawa D, Koike J, Shibagaki Y.

Nephrology (Carlton). 2018 May;23(5):495. doi: 10.1111/nep.13096. No abstract available.

PMID:
29696763
22.

Successful laparoscopic partial gastrectomy and spleen-preserving distal pancreatectomy for gastric duplication cyst connecting with the pancreatic tail.

Kawaida H, Kimura A, Watanabe M, Akaike H, Hosomura N, Kawaguchi Y, Amemiya H, Sudo M, Kono H, Matsuda M, Fujii H, Ichikawa D, Fukasawa M, Takahashi E, Sano K, Inoue T.

Int J Surg Case Rep. 2018;44:176-180. doi: 10.1016/j.ijscr.2018.02.028. Epub 2018 Feb 24.

23.

Detection of fusion gene in cell-free DNA of a gastric synovial sarcoma.

Ogino S, Konishi H, Ichikawa D, Hamada J, Shoda K, Arita T, Komatsu S, Shiozaki A, Okamoto K, Yamazaki S, Yasukawa S, Konishi E, Otsuji E.

World J Gastroenterol. 2018 Feb 28;24(8):949-956. doi: 10.3748/wjg.v24.i8.949.

24.

A successful case of a para-aortic lymphocele treated with autologous peripheral blood injection.

Nishibeppu K, Arita T, Nakanishi M, Kuriu Y, Murayama Y, Shoda K, Kosuga T, Konishi H, Morimura R, Komatsu S, Shiozaki A, Ikoma H, Ichikawa D, Fujiwara H, Okamoto K, Otsuji E.

Radiol Case Rep. 2017 Sep 28;12(4):760-763. doi: 10.1016/j.radcr.2017.08.014. eCollection 2017 Dec.

25.

Prediction models to identify individuals at risk of metabolic syndrome who are unlikely to participate in a health intervention program.

Shimoda A, Ichikawa D, Oyama H.

Int J Med Inform. 2018 Mar;111:90-99. doi: 10.1016/j.ijmedinf.2017.12.009. Epub 2017 Dec 30.

PMID:
29425640
26.

[Outcome of Patients with Pathological Complete Response after Neoadjuvant Chemotherapy in Advanced Esophageal Cancer].

Hikami S, Shiozaki A, Fujiwara H, Konishi H, Arita T, Kosuga T, Morimura R, Murayama Y, Komatsu S, Ikoma H, Kuriu Y, Nakanishi M, Ichikawa D, Okamoto K, Otsuji E.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1796-1798. Japanese.

PMID:
29394779
27.

[A Case of Intestinal Obstruction Caused by a Bezoar after Pylous-Preserving Gastrectomy].

Yamazato Y, Kosuga T, Ichikawa D, Kubota T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Arita T, Morimura R, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Otsuji E.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1269-1271. Japanese.

PMID:
29394603
28.

[Conversion Surgery for Stage IV Gastric Cancer].

Konishi T, Kosuga T, Ichikawa D, Komatsu S, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Arita T, Morimura R, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Otsuji E.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1208-1210. Japanese.

PMID:
29394583
29.

[Long-Term Complete Response of Peritoneal Recurrence from Advanced Gastric Cancer Using CapeOx Therapy Following Radical Gastrectomy].

Nishibeppu K, Komatsu S, Ichikawa D, Kosuga T, Okamoto K, Arita T, Konishi H, Morimura R, Murayama Y, Shiozaki A, Kuriu Y, Ikoma H, Nakanishi M, Fujiwara H, Otsuji E.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1173-1175. Japanese.

PMID:
29394571
30.

Influence of magnesium and parathyroid hormone on cisplatin-induced nephrotoxicity in esophageal squamous cell carcinoma.

Konishi H, Fujiwara H, Itoh H, Shiozaki A, Arita T, Kosuga T, Morimura R, Komatsu S, Ichikawa D, Okamoto K, Otsuji E.

Oncol Lett. 2018 Jan;15(1):658-664. doi: 10.3892/ol.2017.7345. Epub 2017 Nov 3.

31.

Mild case of Hailey-Hailey disease caused by a novel ATP2C1 mutation.

Hanamura T, Takeichi T, Okuno Y, Ichikawa D, Kono M, Akiyama M.

J Dermatol. 2018 Jul;45(7):e207-e208. doi: 10.1111/1346-8138.14241. Epub 2018 Jan 31. No abstract available.

PMID:
29383827
32.

Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer.

Nishibeppu K, Komatsu S, Ichikawa D, Imamura T, Kosuga T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Otsuji E.

BMC Cancer. 2018 Jan 30;18(1):108. doi: 10.1186/s12885-018-4052-z.

33.

Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases.

Nagano C, Nozu K, Morisada N, Yazawa M, Ichikawa D, Numasawa K, Kourakata H, Matsumura C, Tazoe S, Tanaka R, Yamamura T, Minamikawa S, Horinouchi T, Nakanishi K, Fujimura J, Sakakibara N, Nozu Y, Ye MJ, Kaito H, Iijima K.

Clin Exp Nephrol. 2018 Aug;22(4):881-888. doi: 10.1007/s10157-018-1534-x. Epub 2018 Jan 25.

PMID:
29372472
34.

Low plasma levels of miR-101 are associated with tumor progression in gastric cancer.

Imamura T, Komatsu S, Ichikawa D, Miyamae M, Okajima W, Ohashi T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Okamoto K, Fujiwara H, Otsuji E.

Oncotarget. 2017 Sep 13;8(63):106538-106550. doi: 10.18632/oncotarget.20860. eCollection 2017 Dec 5.

35.

Blockade of potassium ion transports enhances hypotonicity-induced cytocidal effects in gastric cancer.

Kosuga T, Shiozaki A, Kudou M, Yamazato Y, Ichikawa D, Komatsu S, Konishi H, Okamoto K, Shoda K, Arita T, Morimura R, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Fujiwara H, Marunaka Y, Otsuji E.

Oncotarget. 2017 Sep 8;8(60):101394-101405. doi: 10.18632/oncotarget.20736. eCollection 2017 Nov 24.

36.

KH-type splicing regulatory protein is involved in esophageal squamous cell carcinoma progression.

Fujita Y, Masuda K, Hamada J, Shoda K, Naruto T, Hamada S, Miyakami Y, Kohmoto T, Watanabe M, Takahashi R, Tange S, Saito M, Kudo Y, Fujiwara H, Ichikawa D, Tangoku A, Otsuji E, Imoto I.

Oncotarget. 2017 Sep 15;8(60):101130-101145. doi: 10.18632/oncotarget.20926. eCollection 2017 Nov 24.

37.

Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma.

Imamura T, Komatsu S, Ichikawa D, Miyamae M, Okajima W, Ohashi T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.

Carcinogenesis. 2018 Feb 9;39(2):263-271. doi: 10.1093/carcin/bgx139.

PMID:
29228320
38.

Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction.

Aratani K, Komatsu S, Ichikawa D, Ohashi T, Miyamae M, Okajima W, Imamura T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.

Oncotarget. 2017 Sep 20;8(48):84112-84122. doi: 10.18632/oncotarget.21109. eCollection 2017 Oct 13.

39.

Construction of a combinatorial pipeline using two somatic variant  calling  methods  for whole exome sequence data of gastric cancer.

Kohmoto T, Masuda K, Naruto T, Tange S, Shoda K, Hamada J, Saito M, Ichikawa D, Tajima A, Otsuji E, Imoto I.

J Med Invest. 2017;64(3.4):233-240. doi: 10.2152/jmi.64.233.

40.

Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.

Okajima W, Komatsu S, Ichikawa D, Miyamae M, Ohashi T, Imamura T, Kiuchi J, Nishibeppu K, Arita T, Konishi H, Shiozaki A, Morimura R, Ikoma H, Okamoto K, Otsuji E.

World J Gastroenterol. 2017 Aug 21;23(31):5650-5668. doi: 10.3748/wjg.v23.i31.5650. Review.

41.

Synthesis and biological evaluation of the natural product komaroviquinone and related compounds aiming at a potential therapeutic lead compound for high-risk multiple myeloma.

Suto Y, Sato M, Fujimori K, Kitabatake S, Okayama M, Ichikawa D, Matsushita M, Yamagiwa N, Iwasaki G, Kiuchi F, Hattori Y.

Bioorg Med Chem Lett. 2017 Oct 1;27(19):4558-4563. doi: 10.1016/j.bmcl.2017.08.054. Epub 2017 Aug 30.

PMID:
28882484
42.

NLR Nod1 signaling promotes survival of BCR-engaged mature B cells through up-regulated Nod1 as a positive outcome.

Hayakawa K, Formica AM, Zhou Y, Ichikawa D, Asano M, Li YS, Shinton SA, Brill-Dashoff J, Núñez G, Hardy RR.

J Exp Med. 2017 Oct 2;214(10):3067-3083. doi: 10.1084/jem.20170497. Epub 2017 Sep 6.

43.

Impact of predicting health-guidance candidates using massive health check-up data: A data-driven analysis.

Ichikawa D, Saito T, Oyama H.

Int J Med Inform. 2017 Oct;106:32-36. doi: 10.1016/j.ijmedinf.2017.08.002. Epub 2017 Aug 4.

PMID:
28870381
44.

A novel phenylphthalimide derivative, pegylated TC11, improves pharmacokinetic properties and induces apoptosis of high-risk myeloma cells via G2/M cell-cycle arrest.

Aida S, Hozumi M, Ichikawa D, Iida K, Yonemura Y, Tabata N, Yamada T, Matsushita M, Sugai T, Yanagawa H, Hattori Y.

Biochem Biophys Res Commun. 2017 Nov 4;493(1):514-520. doi: 10.1016/j.bbrc.2017.08.159. Epub 2017 Sep 1.

PMID:
28867196
45.

CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients.

Matsushita M, Ozawa K, Suzuki T, Nakamura M, Nakano N, Kanchi S, Ichikawa D, Matsuki E, Sakurai M, Karigane D, Kasahara H, Tsukamoto N, Shimizu T, Mori T, Nakajima H, Okamoto S, Kawakami Y, Hattori Y.

Blood Cancer J. 2017 Sep 1;7(9):e601. doi: 10.1038/bcj.2017.84.

46.

Perioperative outcomes of single-port mediastinoscope-assisted transhiatal esophagectomy for thoracic esophageal cancer.

Fujiwara H, Shiozaki A, Konishi H, Kosuga T, Komatsu S, Ichikawa D, Okamoto K, Otsuji E.

Dis Esophagus. 2017 Oct 1;30(10):1-8. doi: 10.1093/dote/dox047.

PMID:
28859387
47.

Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing.

Guzzo C, Ichikawa D, Park C, Phillips D, Liu Q, Zhang P, Kwon A, Miao H, Lu J, Rehm C, Arthos J, Cicala C, Cohen MS, Fauci AS, Kehrl JH, Lusso P.

Sci Immunol. 2017 May 12;2(11). pii: eaam7341. doi: 10.1126/sciimmunol.aam7341.

48.

Reconstruction method as an independent risk factor for postoperative bone mineral density loss in gastric cancer.

Imamura T, Komatsu S, Ichikawa D, Kosuga T, Kubota T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Otsuji E.

J Gastroenterol Hepatol. 2018 Feb;33(2):418-425. doi: 10.1111/jgh.13910.

PMID:
28759709
49.

Tamper-Resistant Mobile Health Using Blockchain Technology.

Ichikawa D, Kashiyama M, Ueno T.

JMIR Mhealth Uhealth. 2017 Jul 26;5(7):e111. doi: 10.2196/mhealth.7938.

50.

Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer.

Imamura T, Komatsu S, Ichikawa D, Miyamae M, Okajima W, Ohashi T, Kiuchi J, Nishibeppu K, Konishi H, Shiozaki A, Morimura R, Ikoma H, Ochiai T, Okamoto K, Taniguchi H, Otsuji E.

Sci Rep. 2017 Jul 18;7(1):5708. doi: 10.1038/s41598-017-06137-8.

Supplemental Content

Loading ...
Support Center